Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call
LANCASTER, Calif.--(BUSINESS WIRE)--Dec 19, 2022--
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it will report financial results for the first quarter of fiscal year 2023, the period ended November 30, 2022, after the close of the financial markets on Wednesday, January 4, 2023.
The Company will host a conference call on January 4, 2023, at 5 p.m. Eastern Standard Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call.
About Simulations Plus
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | Twitter | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221219005749/en/
CONTACT: Simulations Plus Investor Relations
Ms. Renee Bouche
Mr. Brian Siegel
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE SOFTWARE OTHER SCIENCE BIOTECHNOLOGY PHARMACEUTICAL HEALTH ARTIFICIAL INTELLIGENCE TECHNOLOGY
SOURCE: Simulations Plus, Inc.
Copyright Business Wire 2022.
PUB: 12/19/2022 04:06 PM/DISC: 12/19/2022 04:06 PM